|
Removal from Official List
|
2 August 2022 at 9:15am
|
|
Update to Shareholders - Voluntary Delisting from ASX
|
26 July 2022 at 3:40pm
|
|
Update to Shareholders
|
21 June 2022 at 4:00pm
|
|
Update to Shareholders - Declaration of shares as worthless
|
9 June 2022 at 10:30am
|
|
Update to Shareholders
|
23 May 2022 at 10:15am
|
|
Update to shareholders
|
21 April 2022 at 3:50pm
|
|
Update to Shareholders
|
29 March 2022 at 10:30am
|
|
Update to shareholders
|
9 March 2022 at 5:10pm
|
|
Update to shareholders
|
2 March 2022 at 7:15pm
|
|
Update to shareholders
|
16 February 2022 at 9:25am
|
|
Update to Shareholders
|
27 January 2022 at 11:35am
|
|
Update to Shareholders
|
20 January 2022 at 7:15pm
|
|
Update to shareholders
|
13 January 2022 at 1:10pm
|
|
Palla Pharma enters Voluntary Administration
|
17 December 2021 at 1:25pm
|
|
Voluntary Suspension
|
15 December 2021 at 8:40am
|
|
Trading Halt
|
13 December 2021 at 9:05am
|
|
Response to ASX Price Query
|
9 December 2021 at 3:10pm
|
|
Sale and Leaseback of Coolaroo Site
|
26 November 2021 at 10:20am
|
|
Jobkeeper Payments Notice
|
8 November 2021 at 2:30pm
|
|
Resignation and appointment of Chief Financial Officer
|
5 October 2021 at 10:25am
|
|
Investor Update Presentation Conference Call Recording
|
4 October 2021 at 1:30pm
|
|
Investor Update
|
30 September 2021 at 4:30pm
|
|
Interim Financial Report - 30 June 2021
|
30 September 2021 at 4:30pm
|
|
Half Year Results and Investor Update Conference Call
|
22 September 2021 at 10:00am
|
|
Update on lodgement of reviewed half-year financial report
|
9 September 2021 at 4:25pm
|
|
Extension of Reporting Deadline for Interim Financial Report
|
1 September 2021 at 10:05am
|
|
Appendix 4D & Preliminary Interim Report - 30 June 2021
|
31 August 2021 at 6:40pm
|
|
Revised Half Year Reporting Timetable & Results Presentation
|
30 August 2021 at 10:20am
|
|
Half Year Results Presentation and Investor Conference Call
|
18 August 2021 at 9:15am
|
|
European Co-Codamol submissions completed
|
23 June 2021 at 9:45am
|
|
Appointment of Alloga widening UK distribution network
|
21 June 2021 at 8:45am
|
|
Interactive recording and presentation of the 2021 AGM
|
27 May 2021 at 1:35pm
|
|
Results of Annual General Meeting
|
26 May 2021 at 5:20pm
|
|
2021 Annual General Meeting Presentation
|
26 May 2021 at 3:10pm
|
|
Palla Pharma Limited announces new CEO, Mr Giles Moss
|
26 May 2021 at 10:05am
|
|
AGM to be held virtually due to COVID-19 restrictions
|
25 May 2021 at 1:10pm
|
|
PAL Formal Product Launch & Production Partnership Update
|
4 May 2021 at 8:45am
|
|
Notice of Annual General Meeting/Proxy Form
|
19 April 2021 at 3:30pm
|
|
Change of Director's Interest Notice - I. Ross
|
13 April 2021 at 3:35pm
|
|
Change of Director's Interest Notice
|
31 March 2021 at 3:00pm
|
|
Change of Director's Interest Notice
|
31 March 2021 at 2:55pm
|
|
Appendix 2A
|
29 March 2021 at 12:20pm
|
|
Appendix 2A update
|
29 March 2021 at 12:15pm
|
|
Palla Pharma successfully completes Retail Entitlement Offer
|
25 March 2021 at 10:25am
|
|
Palla Pharma 2020 Corporate Governance Statement
|
19 March 2021 at 3:55pm
|
|
Palla Pharma 2020 Appendix 4G
|
19 March 2021 at 3:50pm
|
|
Palla Pharma Annual Report
|
19 March 2021 at 3:45pm
|
|
First Palla Pharma 30/500 Co-Codamol Caplet Order
|
19 March 2021 at 10:30am
|
|
Investor Update
|
17 March 2021 at 11:10am
|
|
Retail Entitlement Offer Booklet
|
9 March 2021 at 12:40pm
|
Palla Pharma